World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6821)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

117

WORD

HTML

4795

Figures (1-1)

359

Tables (1-6)

387

Sum=5712

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

197

Download

506

Sum=703

Sep 7, 2023 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Mak JWY, Law AWH, Law KWT, Ho R, Cheung CKM, Law MF. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. World J Gastroenterol 2023; 29(33): 4942-4961 [PMID: 37731995 DOI: 10.3748/wjg.v29.i33.4942]
URL:	https://www.wjgnet.com/1948-5182/full/v29/i33/4942.htm

Number	Citing Articles
1	Hui Ma, Qing-Zhu Yan, Jing-Ru Ma, Dong-Fu Li, Jun-Ling Yang. Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies. World Journal of Gastroenterology 2024; 30(10): 1295-1312 doi: 10.3748/wjg.v30.i10.1295 Abstract(389) \| Core Tip(386) \| Full Article(HTML)(1920) \| Full Article with Cover (PDF)-1506K(115) \| Full Article (Word)-897K(0) \| Audio-407K(3) \| Peer-Review Report-310K(40) \| Answering Reviewers-316K(40) \| Full Article (PDF)-1251K(153) \| Full Article (XML)-349K(41) \| Times Cited (1) \| Total Visits (4098) \| Open
2	Sergey Morozov, Sergey Batskikh. Reactivation of hepatitis B virus infection – an important aspect of multifaceted problem. World Journal of Gastroenterology 2024; 30(26): 3193-3197 doi: 10.3748/wjg.v30.i26.3193 Abstract(258) \| Core Tip(245) \| Full Article(HTML)(1390) \| Full Article with Cover (PDF)-712K(40) \| Audio-383K(7) \| Peer-Review Report-215K(27) \| Answering Reviewers-281K(30) \| Full Article (PDF)-489K(82) \| Full Article (XML)-59K(30) \| Times Cited (0) \| Total Visits (2877) \| Open
3	Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, Martine Elias, Rayan Kaedbey, Michael P. Chu. Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1446995
4	Michele Barone. Risk of hepatic decompensation from hepatitis B virus reactivation in hematological malignancy treatments. World Journal of Gastroenterology 2024; 30(25): 3147-3151 doi: 10.3748/wjg.v30.i25.3147 Abstract(207) \| Core Tip(224) \| Full Article(HTML)(776) \| Full Article with Cover (PDF)-840K(32) \| Audio-1495K(2) \| Peer-Review Report-167K(19) \| Answering Reviewers-106K(24) \| Full Article (PDF)-365K(59) \| Full Article (XML)-62K(25) \| Times Cited (0) \| Total Visits (2017) \| Open
5	Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402 Abstract(287) \| Core Tip(265) \| Full Article(HTML)(2513) \| Full Article with Cover (PDF)-775K(59) \| Audio-524K(6) \| Peer-Review Report-311K(25) \| Answering Reviewers-140K(25) \| Full Article (PDF)-531K(241) \| Full Article (XML)-259K(19) \| Times Cited (0) \| Total Visits (3974) \| Open
6	Jata Shankar Kumar, Deepanshu Khanna, Premashish Kar. Approach to diagnosis and management of reactivation of chronic hepatitis B. Future Virology 2024; 19(6-7): 273 doi: 10.1080/17460794.2024.2356427
7	Abdullah S. Shaikh, Susan C. Abraham, Lan S. Wang, Harrys A. Torres, Hao Chi Zhang. Viral Hepatitis B Reactivation With Delayed Cholestatic Effect Secondary to Acalabrutinib. ACG Case Reports Journal 2024; 11(6): e01387 doi: 10.14309/crj.0000000000001387
8	Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, Roberta Murru, Roberto Marasca. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers 2024; 16(11): 1996 doi: 10.3390/cancers16111996
9	Francesca Colapietro, Nicola Pugliese, Antonio Voza, Alessio Aghemo, Stella De Nicola. Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis. World Journal of Gastroenterology 2024; 30(9): 1253-1256 doi: 10.3748/wjg.v30.i9.1253 Abstract(289) \| Core Tip(304) \| Full Article(HTML)(1060) \| Full Article with Cover (PDF)-1824K(45) \| Audio-393K(4) \| Peer-Review Report-203K(38) \| Answering Reviewers-107K(39) \| Full Article (PDF)-346K(90) \| Full Article (XML)-35K(33) \| Times Cited (5) \| Total Visits (2875) \| Open
10	Wei-Nung Liu, Ming-Shen Dai, Felicia Lin, Gen-Min Lin. Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. World Journal of Gastroenterology 2024; 30(21): 2748-2750 doi: 10.3748/wjg.v30.i21.2748 Abstract(234) \| Core Tip(226) \| Full Article(HTML)(574) \| Full Article with Cover (PDF)-1684K(28) \| Audio-364K(3) \| Peer-Review Report-310K(20) \| Answering Reviewers-77K(19) \| Full Article (PDF)-336K(49) \| Full Article (XML)-34K(19) \| Times Cited (0) \| Total Visits (1754) \| Open
11	Arzu Altunçekiç Yıldırım, Celali Kurt, Burcu Ülküden, Yeliz Çetinkol. Hepatitis B Virus Reactivation with Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review. Viral Hepatitis Journal 2024; 30(1): 19 doi: 10.4274/vhd.galenos.2024.2024-1-1
12	Bansi P Savaliya, Ramin Shekouhi, Fatima Mubarak, Harsheen K Manaise, Paola Berrios Jimenez, Gabrielle Kowkabany, Reed A Popp, Kyle Popp, Emmanuel Gabriel. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors. World Journal of Gastroenterology 2024; 30(24): 3052-3058 doi: 10.3748/wjg.v30.i24.3052 Abstract(219) \| Core Tip(208) \| Full Article(HTML)(940) \| Full Article with Cover (PDF)-625K(33) \| Audio-289K(3) \| Peer-Review Report-361K(19) \| Answering Reviewers-140K(19) \| Full Article (PDF)-395K(61) \| Full Article (XML)-73K(22) \| Times Cited (0) \| Total Visits (1864) \| Open
13	Matteo Tonnini, Clara Solera Horna, Luca Ielasi. Prevention of hepatitis B reactivation in patients with hematologic malignancies treated with novel systemic therapies: Who and Why?. World Journal of Gastroenterology 2024; 30(5): 509-511 doi: 10.3748/wjg.v30.i5.509 Abstract(302) \| Core Tip(285) \| Full Article(HTML)(1005) \| Full Article with Cover (PDF)-3335K(64) \| Full Article (Word)-106K(9) \| Audio-160K(4) \| Peer-Review Report-198K(33) \| Answering Reviewers-52K(36) \| Full Article (PDF)-335K(77) \| Full Article (XML)-28K(35) \| Times Cited (1) \| Total Visits (2340) \| Open